Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7612)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2019 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang WT, Guo CQ, Cui GH, Zhao S. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(37): 5604-5618 [PMID: PMC6785517 DOI: 10.3748/wjg.v25.i37.5604] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i37/5604.htm |
| Number | Citing Articles |
| 1 |
Meng-Xiang Li, Xiao-Meng Sun, Wei-Gang Cheng, Hao-Jie Ruan, Ke Liu, Pan Chen, Hai-Jun Xu, She-Gan Gao, Xiao-Shan Feng, Yi-Jun Qi. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08647-1
|
| 2 |
Hajime Ishinaga, Yoshinaga Okugawa, Bo Hou, Feng He, Chengzeng Yin, Mariko Murata, Yuji Toiyama, Kazuhiko Takeuchi. The role of miR-21 as a predictive biomarker and a potential target to improve the effects of chemoradiotherapy against head and neck squamous cell carcinoma. Journal of Radiation Research 2023; 64(4): 668 doi: 10.1093/jrr/rrad043
|
| 3 |
Xiao Yan Wen, Ru Yi Wang, Bei Yu, Yue Yang, Jin Yang, Han Chao Zhang. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42858-9
|
| 4 |
Yong Yu, Kai-Ming Ren. Development of a prognostic prediction model based on microRNA-1269a in esophageal cancer. World Journal of Gastrointestinal Oncology 2021; 13(8): 941 doi: 10.4251/wjgo.v13.i8.941
|
| 5 |
Pornima Phatak, Mohan E. Tulapurkar, Whitney M. Burrows, James M. Donahue. MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B. Cancers 2023; 15(19): 4811 doi: 10.3390/cancers15194811
|
| 6 |
Dylan P. McClurg, Chandan Sanghera, Somnath Mukherjee, Rebecca C. Fitzgerald, Christopher M. Jones. A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer. Radiotherapy and Oncology 2024; 195: 110224 doi: 10.1016/j.radonc.2024.110224
|
| 7 |
Hanjing Gao, Zheng Yan, Haiyan Sun, Yanfang Chen. FoXA2 promotes esophageal squamous cell carcinoma progression by ZEB2 activation. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02358-4
|
| 8 |
Lei-Ming Guo, Gao-Feng Ding, Wen-Cai Xu, Hong Ge, Yue Jiang, Yu-Fei Lu, Sander Bekeschus. Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/5938688
|
| 9 |
Zheng Han, Lingbo Pan, Bangjie Lu, Huixia Zhu. MicroRNA-21 as a potential biomarker for detecting esophageal carcinoma in Asian populations: a meta-analysis. PeerJ 2022; 10: e14048 doi: 10.7717/peerj.14048
|
| 10 |
Sena Babadag, Özlem Altundag-Erdogan, Yeliz Z. Akkaya-Ulum, Betül Çelebi-Saltik. The role of telocytes and miR-21-5p in tumorigenicity and metastasis of breast cancer stem cells. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09352-5
|
| 11 |
Giovanni Zarrilli, Francesca Galuppini, Valentina Angerilli, Giada Munari, Marianna Sabbadin, Vanni Lazzarin, Lorenzo Nicolè, Rachele Biancotti, Matteo Fassan. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. International Journal of Molecular Sciences 2021; 22(7): 3640 doi: 10.3390/ijms22073640
|
| 12 |
Yong Yu, Kai-Ming Ren. Development of a prognostic prediction model based on microRNA-1269a in esophageal cancer. World Journal of Gastrointestinal Oncology 2021; 13(8): 943-958 doi: 10.4251/wjgo.v13.i8.943
|
| 13 |
Bo Min, Yan Wang, Feng Liang, Cheng-Xiang Wang, Fan Wang, Zhi Yang, Zhongjie Shi. The Protective Mechanism of Afuresertib against Esophageal Cancer. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1832241
|
| 14 |
Ying Xue, Kai Wang, Yunli Jiang, Yanmiao Dai, Xiaoyu Liu, Bing Pei, Hui Li, Hongwei Xu, Guodong Zhao. An ultrasensitive and multiplexed miRNA one-step real time RT-qPCR detection system and its application in esophageal cancer serum. Biosensors and Bioelectronics 2024; 247: 115927 doi: 10.1016/j.bios.2023.115927
|
| 15 |
Luquan Zhang, Hao Liang, Yanzhong Xin. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway. Anti-Cancer Drugs 2020; 31(8): 847 doi: 10.1097/CAD.0000000000000961
|
| 16 |
Zhenglin He, Yishuo Ji, Yutong Yuan, Tianfang Liang, Chenglin Liu, Yiping Jiao, Yimeng Chen, Yiming Yang, Liang Han, Yue Hu, Xianling Cong. Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1532558
|
| 17 |
Ryosuke Hirohata, Yuki Yamamoto, Takahiro Mimae, Yoichi Hamai, Yuta Ibuki, Ryou-u Takahashi, Morihito Okada, Hidetoshi Tahara. Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy. Annals of Surgical Oncology 2025; 32(1): 570 doi: 10.1245/s10434-024-16247-z
|